Aclara Reports Shrinking Revenues, R&D Expenses, Losses for Q4; Wins Pfizer as Customer | GenomeWeb

NEW YORK, Jan. 29 (GenomeWeb News) - Aclara BioSciences reported decreased revenues, losses, and R&D expenses for the fourth quarter of 2003 yesterday, and said it has won Pfizer as a customer for its eTag assay system.

 

The company's fourth quarter revenues fell to $653,000 from $752,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.